We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
Cap. Flow
-$4.42B
Cap. Flow %
-10.38%
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$244M
2
PFE icon
Pfizer
PFE
+$234M
3
NKE icon
Nike
NKE
+$201M
4
TSLA icon
Tesla
TSLA
+$200M
5
SPGI icon
S&P Global
SPGI
+$196M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Healthcare 11.63%
3 Consumer Discretionary 11.09%
4 Financials 10.76%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTHR
2926
DELISTED
Charles & Colvard Ltd
CTHR
$6.42K ﹤0.01%
1,884
STLNW
2927
Starling Oncology, Inc. Warrant
STLNW
$5.04M
$6K ﹤0.01%
30,000
CDROW icon
2928
Codere Online Luxembourg Warrants
CDROW
$5.28M
$5.93K ﹤0.01%
12,413
ZURAW
2929
DELISTED
Zura Bio Limited Warrants
ZURAW
$5.8K ﹤0.01%
21,500
PAYOW
2930
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$5.6K ﹤0.01%
20,731
SST.WS
2931
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
$4.86K ﹤0.01%
33,500
-12,200
-27% -$1.34K
SES.WS icon
2932
SES AI Corp Warrants
SES.WS
$4.82M
$4.51K ﹤0.01%
56,326
CNTN
2933
Canton Strategic Holdings
CNTN
$144M
$4.48K ﹤0.01%
+694
New +$4.35K
ECXWW
2934
ECARX Holdings Warrants
ECXWW
$4.33K ﹤0.01%
144,200
SRTAW
2935
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$3.9K ﹤0.01%
37,300
GMDA
2936
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$3.83K ﹤0.01%
106,081
-18,145
-15% -$6.2K
NOTE.WS
2937
DELISTED
FiscalNote Holdings Warrants
NOTE.WS
$3.42K ﹤0.01%
13,695
VGASW icon
2938
Verde Clean Fuels Warrant
VGASW
$728K
$3.32K ﹤0.01%
14,000
EZGO
2939
EZGO Technologies
EZGO
$2.44M
0
JAGX icon
2940
Jaguar Health
JAGX
$4.67M
$2.34K ﹤0.01%
+1
New +$4.38K
GGE
2941
DELISTED
Green Giant Inc. Common Stock
GGE
$1.76K ﹤0.01%
55,972
-47,554
-46% -$1.81K
FFAI
2942
Faraday Future Intelligent Electric
FFAI
$10.5M
$1.36K ﹤0.01%
2
+1
+100% +$1.76K
SBFM
2943
Sunshine Biopharma
SBFM
$2.93M
$1.16K ﹤0.01%
+1
New +$2.94K
DVLT
2944
Datavault AI
DVLT
$263M
$397 ﹤0.01%
+128
New +$1.25K
CMAXW
2945
DELISTED
CareMax, Inc. Warrant
CMAXW
$374 ﹤0.01%
21,865
MSPRW
2946
DELISTED
MSP Recovery Inc Warrant
MSPRW
$133 ﹤0.01%
36,900
A icon
2947
Agilent Technologies
A
$41.2B
-67,493
Closed -$9.38M
AAL icon
2948
American Airlines Group
AAL
$10.6B
-7,088,113
Closed -$103M
ABEO icon
2949
Abeona Therapeutics
ABEO
$413M
-56,948
Closed -$285K
ACIW icon
2950
ACI Worldwide
ACIW
$5.42B
-35,100
Closed -$1.07M

Similar funds

Two Sigma Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.

  • Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
  • Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
  • Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
  • Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
  • Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
  • Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
  • Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.